News

By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director General of Gustave Roussy, effective 1 August 2026. 

« Great advances in oncology » – Episode 3/4. Now considered indispensable in oncology, molecular profiling of tumours is one of the cornerstones of precision medicine. As early as 2011, three physician-researchers at Gustave Roussy outlined its key principles in an article published in the Journal of Clinical Oncology, with a clear ambition: to...

“Great Advances in Oncology” – Episode 2/4. Discovered more than three decades ago at Gustave Roussy, the LAG‑3 gene is now at the heart of the development of new anticancer treatments. By targeting it, scientists aim to remove one of the brakes that can limit the immune system’s ability to fight cancer cells. 

Summer invites us outdoors — vacations, walks, long days in the sun. But enjoying the sunshine shouldn't mean forgetting the risks linked to ultraviolet (UV) radiation, the leading cause of premature skin ageing and skin cancer. Choosing the right sunscreen, applying it correctly, and adopting good habits are the best allies for enjoying summer...

Inserm – the French National Institute of Health and Medical Research – is the only French public research organisation entirely dedicated to human health. Each year, its new tenured research fellows are recruited through a highly selective competitive process. For the 2026 edition, five young researchers from Gustave Roussy are among the awardees...

"Great Advances in Oncology” – Episode 1/4. Developed in the 1940s by Professor Pierre Denoix, the TNM classification has gradually become the tool that enables oncologists worldwide to determine the stage of their patients’ cancer within a unified framework. Still in use today, it reached its 9th edition in 2025.

The Cancer Research Institute (CRI) has awarded the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology to Prof. Éric Vivier, holder of the Natural Killer (NK) Cell Chair of the Fondation Gustave Roussy. This distinction, one of the most prestigious in cancer immunology, recognizes his body of work, which has profoundly...

The ERC (European Research Council) Proof of Concept grant awarded to Alexandre Detappe (Gustave Roussy/Institut Strauss/Université Paris-Saclay/Inserm) will fund the Nano-BITE project, which aims to improve the ability of the immune system to fight solid tumors through nanomedicine. The goal is to develop a new generation of immunotherapies that...

Building on the success of its first two editions, the Gustave Roussy Prize, which recognizes a researcher whose discoveries have had a major impact on the care of patients living with cancer, will be held again in 2027. Applications are open until August 26, 2026, at 4:00 p.m. CEST. Endowed with €200,000, this prestigious prize will be awarded on...

From 17 to 19 June in Paris, the IFODS Congress, a benchmark event for French-speaking oncology, will highlight the latest advances in the global fight against cancer, with insights from leading experts. On Thursday, 18 June, an IFODS/Gustave Roussy presidential session will take stock of key topics in oncology. On the programme: therapeutic...